| Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer B Wingelhofer, HA Neubauer, P Valent, X Han, SN Constantinescu, ... Leukemia, doi: 10.1038/s41375-018-0117-x., 2018 | 207 | 2018 |
| Roles, regulation and inhibitors of sphingosine kinase 2 HA Neubauer, SM Pitson The FEBS journal 280 (21), 5317-5336, 2013 | 190 | 2013 |
| Tumor target amplification: Implications for nano drug delivery systems K Seidi, HA Neubauer, R Moriggl, R Jahanban-Esfahlan, T Javaheri Journal of Controlled Release 275, 142-161, 2018 | 119 | 2018 |
| STAT3 and STAT5 activation in solid cancers S Igelmann, HA Neubauer, G Ferbeyre Cancers 11 (10), 1428, 2019 | 87 | 2019 |
| Structural and functional consequences of the STAT5BN642H driver mutation ED de Araujo, F Erdogan, HA Neubauer, D Meneksedag-Erol, ... Nature communications 10 (1), 2517, 2019 | 77 | 2019 |
| Direct targeting options for STAT3 and STAT5 in cancer A Orlova, C Wagner, ED de Araujo, D Bajusz, HA Neubauer, M Herling, ... Cancers 11 (12), 1930, 2019 | 75 | 2019 |
| Pharmacological inhibition of oncogenic STAT3 and STAT5 signaling in hematopoietic cancers M Brachet-Botineau, M Polomski, HA Neubauer, L Juen, D Hédou, ... Cancers 12 (1), 240, 2020 | 66 | 2020 |
| An oncogenic role for sphingosine kinase 2 HA Neubauer, DH Pham, JR Zebol, PAB Moretti, AL Peterson, ... Oncotarget 7 (40), 64886, 2016 | 65 | 2016 |
| Structural implications of STAT3 and STAT5 SH2 domain mutations ED de Araujo, A Orlova, HA Neubauer, D Bajusz, HS Seo, ... Cancers 11 (11), 1757, 2019 | 55 | 2019 |
| NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth K Seidi, R Jahanban-Esfahlan, H Monhemi, P Zare, B Minofar, ADF Adli, ... Oncogene, doi:10.1038/s41388-018-0213-4., 2018 | 53 | 2018 |
| CIB2 negatively regulates oncogenic signaling in ovarian cancer via sphingosine kinase 1 W Zhu, KE Jarman, NA Lokman, HA Neubauer, LT Davies, BL Gliddon, ... Cancer research 77 (18), 4823-4834, 2017 | 34 | 2017 |
| Opioids drive breast cancer metastasis through the δ-opioid receptor and oncogenic STAT3 S Tripolt, HA Neubauer, VM Knab, DP Elmer, F Aberger, R Moriggl, ... Neoplasia 23 (2), 270-279, 2021 | 31 | 2021 |
| Development of HDAC inhibitors exhibiting therapeutic potential in T-cell prolymphocytic leukemia K Toutah, N Nawar, S Timonen, H Sorger, YS Raouf, S Bukhari, J von Jan, ... Journal of medicinal chemistry 64 (12), 8486-8509, 2021 | 29 | 2021 |
| KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis T Limberger, M Schlederer, K Trachtová, I Garces de los Fayos Alonso, ... Molecular Cancer 21 (1), 89, 2022 | 27 | 2022 |
| The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5 D Kadekar, R Agerholm, J Rizk, HA Neubauer, T Suske, B Maurer, ... The Journal of Clinical Investigation 130 (5), 2496-2508, 2020 | 26* | 2020 |
| Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma HA Neubauer, MN Tea, JR Zebol, BL Gliddon, C Stefanidis, PAB Moretti, ... Oncogene 38 (8), 1151-1165, 2019 | 26 | 2019 |
| Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas A Orlova, B Wingelhofer, HA Neubauer, B Maurer, A Berger-Becvar, ... Expert opinion on therapeutic targets 22 (1), 45-57, 2018 | 20 | 2018 |
| Thyroid and androgen receptor signaling are antagonized by μ‐crystallin in prostate cancer O Aksoy, J Pencik, M Hartenbach, AA Moazzami, M Schlederer, T Balber, ... International journal of cancer 148 (3), 731-747, 2021 | 18 | 2021 |
| The diverse roles of γδ T cells in cancer: from rapid immunity to aggressive lymphoma S Schönefeldt, T Wais, M Herling, S Mustjoki, V Bekiaris, R Moriggl, ... Cancers 13 (24), 6212, 2021 | 16 | 2021 |
| Kelch-like protein 5-mediated ubiquitination of lysine 183 promotes proteasomal degradation of sphingosine kinase 1 JA Powell, MR Pitman, JR Zebol, PAB Moretti, HA Neubauer, LT Davies, ... Biochemical Journal 476 (21), 3211-3226, 2019 | 15 | 2019 |
